Comment
doi: 10.1097/01.tp.0000235431.71677.e3.
Cardiovascular disease management in renal transplant recipients: more or less treatment?
Affiliations
- PMID: 17006317
- DOI: 10.1097/01.tp.0000235431.71677.e3
Item in Clipboard
Comment
Cardiovascular disease management in renal transplant recipients: more or less treatment?
Transplantation.
.
No abstract available
Comment on
-
Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.Transplantation. 2006 Sep 27;82(6):771-8. doi: 10.1097/01.tp.0000235446.50715.ef. Transplantation. 2006. PMID: 17006324 Clinical Trial.
Similar articles
-
[Late complications following renal transplantation].Ned Tijdschr Geneeskd. 2008 Jun 7;152(23):1317-21. Ned Tijdschr Geneeskd. 2008. PMID: 18661857 Review. Dutch.
-
Nutritional and metabolic issues in solid organ transplantation: targets for future research.J Ren Nutr. 2009 Jan;19(1):111-22. doi: 10.1053/j.jrn.2008.10.020. J Ren Nutr. 2009. PMID: 19121784 Review.
-
Overview of renal transplantation.Minerva Med. 2007 Dec;98(6):713-29. Minerva Med. 2007. PMID: 18299684 Review.
-
[Hypertension after kidney transplantation].Lijec Vjesn. 2006 Nov-Dec;128(11-12):373-8. Lijec Vjesn. 2006. PMID: 17212200 Review. Croatian.
-
A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.Transplantation. 2006 Oct 15;82(7):924-30. doi: 10.1097/01.tp.0000239313.83735.33. Transplantation. 2006. PMID: 17038908
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
